Open Clinical Trials:
CLINICAL TRIAL 20491
A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 Antitrypsin (AAT) Combined with Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD Following Allogeneic Hematopoietic Stem Cell Transplant
Disease Site: Graft vs Host Disease (GVHD), Unknown Sites
View Trial DetailsCLINICAL TRIAL 21114
AGAVE-201, A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients with Recurrent or Refractory Active Chronic Graft Versus Host Disease who have Received at least 2 Lines of Systemic Therapy
Disease Site: Graft vs Host Disease (GVHD), Unknown Sites
View Trial Details